DRTSW Alpha Tau Medical Ltd. - Warrant
3.920USD-1.26%Mkt Cap: —P/E: —6d ago
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid ca…
Industry Peers
Health Information Services$45.74BUSDP/E 46.3
$12.69BUSD
$12.62BUSDP/E 56.5
$7.90BUSDP/E 32.3
$7.60BUSDP/E 33.2
$4.94BUSDP/E 36.8
$4.94BUSDP/E 32.6
$4.29BUSD
$2.59BUSDP/E 96.7
$2.04BUSD
$1.61BUSDP/E 41.9
$1.37BUSD
$1.28BUSDP/E 87.0
$1.11BUSDP/E 65.0
$1.01BUSD
$982.13MUSDP/E 44.6
$651.74MUSDP/E 61.8
$608.66MUSD
$592.92MUSD
$521.70MUSDP/E 29.4
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-42.63M USD
Revenue/Share—
Last Price3.920 USD
Fiscal Year End—
MR Quarter—
Employees121
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B8.28
EPS (TTM)—
EPS (Forward)—
52W Range
1.02085% of range4.450
52W High4.450 USD
52W Low1.020 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-55.29%
ROA-40.35%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-26.68M USD
CapEx (TTM)6.08M USD
FCF Margin—
FCF Yield—
Net Debt-85.49M USD
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.18
Current Ratio11.09
Quick Ratio10.45
Book Value/Sh0.48 USD
Cash/Share1.09 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float64.10M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.22
S&P 52W Chg15.78%
Avg Vol (30d)54.86K
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—